Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency |
|
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry |
|
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs |
|
B cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. |
|
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience |
|
The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018) |
|
Hyper IgM Syndrome: a Report from the USIDNET Registry |
|
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. |
|
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management |
|
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers |
|
The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. |
|
Progress toward less toxic conditioning. |
|
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts |
|
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery |
|
Transplantation outcomes for severe combined immunodeficiency, 2000-2009. |
|